Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Movement Disorders Clinical Practice|February 14, 2026
Risk-Benefit Considerations in Deep Brain Stimulation Discontinuation for Late-Stage Parkinson's DiseasePietro Antenucci, Andrea Gozzi, Fabiana Colucci, et al.Movement Disorders Clinical Practice|July 15, 2025
Opicapone in Parkinson's Disease on Levodopa-Carbidopa Intestinal Gel Treatment: A Pilot, Randomized StudyFabiana Colucci, Andrea Gozzi, Pietro Antenucci, et al.Journal of Clinical Medicine|August 29, 2024
Cognition in Patients with Spinocerebellar Ataxia 1 (SCA1) and 2 (SCA2): A Neurophysiological and Neuropsychological ApproachFabiana Colucci, Sara Stefanelli, Elena Contaldi, et al.Scientific Reports|February 10, 2025
Time perception in cerebellar and basal ganglia stroke patientsAnnibale Antonioni, Emanuela Maria Raho, Mariagrazia Capizzi, et al.Journal of Neurology|August 10, 2024
Thalamic ventral-Oralis complex/rostral zona incerta deep brain stimulation for midline tremorAlba Scerrati, Andrea Gozzi, Michele Alessandro Cavallo, et al.Clinical Neurology and Neurosurgery|May 26, 2026
Uninterrupted oral anticoagulation plus short-term single antiplatelet therapy in anticoagulated patients undergoing carotid artery stentingGianvito Barbella, Alessandro De Vito, Renato Simonetti, et al.NPJ Parkinson'S Disease|July 14, 2026
STN-DBS and LCIG differentially affect long-term axial symptoms in Parkinson's diseaseFabiana Colucci, Ahmet Kaymak, Pietro Antenucci, et al.Movement Disorders Clinical Practice|November 21, 2025
Titration Dynamics and Early Treatment Burden in Advanced Parkinson's Disease: A Multicenter Comparison of CSFLI and LCIG Infusion TherapiesBeatrice Pinna, Giuseppe Fenu, Paolo Mellino, et al.Neurology|October 22, 2025
Long-Term Motor and Cognitive Outcome of Deep Brain Stimulation in Patients With Parkinson Disease With a GBA1 Pathogenic VariantMicol Avenali, Carlo Alberto Artusi, Roberto Cilia, et al.European Journal of Neurology|July 15, 2025
Effects of GBA1 Variants in Patients With Parkinson's Disease and Levodopa-Carbidopa Intestinal Gel: A Nation-Wide, Multicenter, Longitudinal, "Real-World" Study. The EPIC StudyRoberto Cilia, Fabiana Colucci, Emanuele Cereda, et al.Pageof 2